Explore how PPARγ, a nuclear receptor originally studied for metabolism, has emerged as a promising cancer therapy target through its dual role in tumor regulation.
Explore how antibody-drug conjugates (ADCs) are transforming cancer treatment through targeted therapy, analytical characterization, and regulatory considerations.
Explore how near-infrared light-activated nanomachines using upconversion nanoparticles and azobenzene-modified silica are revolutionizing targeted cancer therapy.
Exploring how synthetic indole alkaloids derived from natural compounds are revolutionizing cancer treatment through targeted therapy and reduced toxicity.
The 70-year journey of azadipyrromethenes from simple blue pigments to cutting-edge cancer fighters and imaging tools.
Exploring the medical applications of protonated tetraaza complexes in cancer therapy and diagnostic imaging.